CClinicalTrials.gg
Sign In
Status unknownNCT02315313Updated Dec 11, 2014

The Link Between the Clinical Resting Heart Rate and Sympathetic Overactivation

An observational study in Cardiovascular Disease, sponsored by Ruijin Hospital. Status unknown. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2014-12-11.

Sponsored by Ruijin Hospital · Observational

The sponsor has not verified this record recently (last verified Dec 2014), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
1,000
Ages
20 Years to 80 Years
Sex
All
01

Study summary

It is a retrospective study with no products limitation to investigate the link between clinical resting HR and SOA. Use HR≤60bpm as control group, compare other three groups with the control group and find out the correlation between HR and SOA indexes.

02

Conditions studied

  • Cardiovascular Disease
03

In context

Cardiovascular Diseases

4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 573 across 1,485 observational studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

Ruijin Hospital is the lead sponsor of 635 studies on the registry; 359 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

cardiovascular disease patient

Inclusion criteria

  1. Provision of subject informed written or oral consent
  2. Female and male aged≥ 20 to ≤ 80 years;
  3. Records on mean clinical heart rate and SOA indexes were available.

Exclusion criteria

Exclusion Criteria:

  1. Participation in another clinical study with an investigational product during the last 6 months;
  2. Drug intervention on heart rate 1 month prior to the inclusion;
  3. Patients with missing data in the database from the Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • group1

    RHR≤60bpm

  • group2

    RHR 61-70bpm

  • group3

    RHR 71-80bpm

  • group4

    RHR \>80bpm

06

What researchers measure

Primary outcomes

  1. The difference of HRV, BPV, LF/HF between each groups

    The difference on mean sympathetic overactivation related indexes such as HRV, BPV, LF/HF between groups

    Time frame: 1min HR measure

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02315313
Lead sponsor
Ruijin Hospital
Responsible party
Wang Jiguang (Director, The Shanghai Institute of Hypertension, Ruijin Hospital) — Principal investigator
First posted
Dec 11, 2014
Start date
Dec 2014
Primary completion
Dec 2015 (estimated)
Last update
Dec 11, 2014

Study contacts

Jiguang Wang, PHD
Contact
wangjiguang2000@126.com
13764189476

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Cardiovascular Diseases→

Other studies from this sponsor

Ruijin Hospital

Start the discussion